Integrating Genomic Data into the Clinical Workflow | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Integrating Genomic Data into the Clinical Workflow

April 16, 2015
by Kayt Sukel
| Reprints
Click To View Gallery

The era of clinical genomics is upon us.  How will technologies like whole genome sequencing, and the exobytes of data these laboratory processes create, transform the face of clinical care?  These are the questions that Mark Blatt, WW Medical Director at Intel, and James Lowey, Vice President of Technology at TGen, attempted to answer yesterday afternoon in their HIMSS15 E-Session, "Using Genomic Data to Make a Difference in Clinical Care."

Dr. Blatt started the session with a video about Shelby, a young girl with a rare genetic disorder.  Shelby was wheelchair bound and no one was sure what was wrong with her--until her doctors were able to perform the sequencing to identify her genetic defect.  Once found, doctors were able to treat Shelby.  And she is now wheelchair-free.  Her story is a wonderful example of how whole genome sequencing can inform the diagnosis and treatment of both common and rare diseases.

Blatt discussed how whole genome sequencing (WGS) has moved from the bench to the bedside.  And he addressed some of the technological issues involved with using it for clinical decision support.  For example, WGS processes create a phenomenal amount of data.  "Storing these amounts of data is a problem," he said,  "Moving this data is a problem.  Genomic data consumes a tremendous amount of resources.  It is the epitome of big data." 

And those are problems we need to address--now rather than later.  Because even today, WGS is being used more and more.  And as WGS is expected to one day only cost $100 and take less than an hour to process, it is going to quickly become a viable lab test for everyday patients.

James Lowey took over the presentation to discuss some of these technical issues--and how TGen is helping to move genomics from bench to bedside.  He explained advancements in computing infrastructure and real-time analytics of both structured and unstructured data.  And he discussed how these tools, as well as practical changes in both research and clinical workflows can make personalized medicine, through the use of WGS, a reality.

This HIMSS15 E-Session, "Using Genomic Data to Make a Difference in Clinical Care," is available on demand on HIMSS15 Online. 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Cedars-Sinai Collaborates on Organs-on-Chip Precision Medicine Project

Scientists at Los Angeles-based Cedars-Sinai, in partnership with biotechnology startup Emulate, are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.

Blockchain Company Hashed Health Gets New Partner

ODH, Inc., a New Jersey-based health technology company, has joined with blockchain innovation consortium Hashed Health.

NCQA Approved by Government as ONC-Authorized Testing Lab

The National Committee for Quality Assurance (NCQA) has announced that its eMeasure testing laboratory is now approved by the Office of the National Coordinator for Health Information Technology (ONC).

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.